Uncategorized
Nike’s Sneaker Buzz And Tariff Risks Could Shape Its Future: Analyst
Nike Inc. (NYSE: NKE) is gaining momentum with high-heat sneaker drops and its new ReactX Rejuven8 slip-ons, says Needham’s Tom Nikic. The analyst highlights tariff risks and rising buzz around Nike’s innovations, which could challenge rivals like Crocs Inc. (NASDAQ: CROX). Latest Ratings for NKE Date Firm Action From To Mar 2022 Cowen & Co….
Breaking Down Western Digital: 24 Analysts Share Their Views
Latest Ratings for WDC Date Firm Action From To Mar 2022 Stifel Maintains Buy Jan 2022 Mizuho Maintains Buy Jan 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for WDC View the Latest Analyst Ratings read more
Compass Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)
Latest Ratings for COMP Date Firm Action From To Feb 2022 Needham Maintains Buy Jan 2022 Berenberg Initiates Coverage On Buy Nov 2021 Barclays Maintains Equal-Weight View More Analyst Ratings for COMP View the Latest Analyst Ratings read more
Omeros’ New Leukemia Drug Team Ignites Hope For Cancer Fight
Omeros forms oncology committee to guide development of its AML therapy, which showed strong efficacy and safety in preclinical studies targeting leukemia cells. Latest Ratings for OMER Date Firm Action From To Oct 2021 HC Wainwright & Co. Maintains Buy Oct 2021 JP Morgan Downgrades Neutral Underweight Oct 2021 HC Wainwright & Co. Maintains Buy…
Breaking Down Globus Medical: 5 Analysts Share Their Views
Latest Ratings for GMED Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Credit Suisse Maintains Outperform Feb 2022 Needham Maintains Buy View More Analyst Ratings for GMED View the Latest Analyst Ratings read more
The Analyst Verdict: Clean Harbors In The Eyes Of 10 Experts
Latest Ratings for CLH Date Firm Action From To Jan 2022 Raymond James Upgrades Outperform Strong Buy Nov 2021 Raymond James Maintains Outperform Nov 2021 Needham Maintains Buy View More Analyst Ratings for CLH View the Latest Analyst Ratings read more
What’s Next for Silver After a Sharp Climb in Q1-25?
Silver stands at a crossroads in 2025, balancing its industrial promise with its safe-haven allure. So, what’s next for Silver? read more
Analyst Expectations For OrthoPediatrics’s Future
Latest Ratings for KIDS Date Firm Action From To Mar 2022 Needham Maintains Buy Dec 2021 BTIG Maintains Buy Dec 2021 Truist Securities Maintains Buy View More Analyst Ratings for KIDS View the Latest Analyst Ratings read more
Analyst Expectations For Lovesac’s Future
Latest Ratings for LOVE Date Firm Action From To Sep 2021 Roth Capital Maintains Buy Sep 2021 BTIG Maintains Buy Jun 2021 DA Davidson Maintains Buy View More Analyst Ratings for LOVE View the Latest Analyst Ratings read more